STAT+: FDA takes applications for new program to shorten drug approval times

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: FDA takes applications for new program to shorten drug approval timesWorldPing
Image via STAT.

What happened

The FDA is opening applications for a pilot program designed to shorten drug approval timelines and help the U.S. compete with countries like China and Australia.

Key facts

  • The FDA is opening applications for a pilot program designed to shorten drug approval timelines and help the U.S. compete with countries like China and Australia.
  • Reported by STAT and published Tue, 15 Sep 2026 14:00:00 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage

Hacker News
WorldPing
Hacker News

Global bond yields hit 2008 highs, raising stakes for big borrowers

Article URL: https://www.reuters.com/world/asia-pacific/bond-selloff-drives-us-benchmark-beyond-5-stocks-rattled-2026-09-15/ Comments URL: https://news.ycombinator.com/item?id=49712746 Points: 86 # Comments: 70…

Brief by WorldPing · Original reporting by Hacker News